Guangzhou Baiyunshan Pharmaceutical Stock Z Score
GZPHFDelisted Stock | USD 2.88 0.00 0.00% |
Guangzhou |
Guangzhou Baiyunshan Pharmaceutical Company Z Score Analysis
Guangzhou Baiyunshan's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Guangzhou Baiyunshan Z Score | 6.4 |
Most of Guangzhou Baiyunshan's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangzhou Baiyunshan Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Guangzhou Baiyunshan Pharmaceutical has a Z Score of 6.4. This is 5.19% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The z score for all United States stocks is 26.61% higher than that of the company.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Guangzhou Fundamentals
Return On Equity | 0.13 | |||
Return On Asset | 0.0356 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.05 % | |||
Current Valuation | 5.65 B | |||
Shares Outstanding | 219.9 M | |||
Shares Owned By Institutions | 33.99 % | |||
Price To Earning | 6.77 X | |||
Price To Book | 0.78 X | |||
Price To Sales | 0.11 X | |||
Revenue | 69.01 B | |||
Gross Profit | 13.19 B | |||
EBITDA | 5.46 B | |||
Net Income | 3.72 B | |||
Cash And Equivalents | 21.72 B | |||
Cash Per Share | 13.36 X | |||
Total Debt | 752.81 M | |||
Debt To Equity | 0.33 % | |||
Current Ratio | 1.65 X | |||
Book Value Per Share | 19.33 X | |||
Cash Flow From Operations | 5.67 B | |||
Earnings Per Share | 0.35 X | |||
Number Of Employees | 25.44 K | |||
Beta | 0.7 | |||
Market Capitalization | 6.95 B | |||
Total Asset | 66.12 B | |||
Z Score | 6.4 | |||
Annual Yield | 0.04 % | |||
Net Asset | 66.12 B | |||
Last Dividend Paid | 0.69 |
About Guangzhou Baiyunshan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangzhou Baiyunshan Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangzhou Baiyunshan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangzhou Baiyunshan Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Guangzhou Pink Sheet
If you are still planning to invest in Guangzhou Baiyunshan check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guangzhou Baiyunshan's history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |